Creating a Generation of Drugged Children

Last November, the journal Pediatrics published research that found medication use among children across the United States is dramatically increasing as more kids are being treated for diabetes, hypertension, obesity, asthma, and attention-deficit hyperactivity disorder (ADHD). Using a database of prescription claims from children with private health insurance, they were able to find prescriptions for […]

Read More

FDA to Receive More Money from Drug Manufacturers, But Denies “Undue Influence”

The proposed budget of the US Food and Drug Administration (FDA) is worrying the Democrats. They are concerned that FDA’s annual increases in industry user fees—$828 million from manufacturers of medical and food products, including hundreds of millions drug manufacturers pay annually to help speed the review of new medicines—might compromise the agency’s independence.

Read More

Nineteen Members of Congress Ask FDA for Official Warning About Mercury in Dental Filling Amalgams

A bipartisan letter authored by Rep. Diane Watson (D-CA) and Rep. Dan Burton (R-IN), and co-signed by congresswomen and men from twelve states, has been sent to the FDA urging them to require clear warnings about mercury toxicity to every dental patient, and to establish specific protections for children and young women.

Read More

Why Is FDA Protecting the BPA Lobby?

As we have reported in previous issues of Pulse of Health Freedom, bisphenol A (BPA), a chemical in the packaging or contents of many products, may cause long-term health effects, including cancers of the breast, brain and testicles; lowered sperm counts, early puberty and other reproductive system defects; diabetes; attention deficit disorder, asthma, and autism. […]

Read More

Ensnared by an Undercover Investigation, Drug Study Reviewer Halts Many of Its Review Operations

A previous Pulse of Health Freedom issue mentioned the uncover operations of the Government Accountability Office (GAO) which ensnared Coast IRB, LLC, of Colorado Springs. The GAO created a fake medical study of a fake product to see whether for-profit review boards adequately supervised medical trials. Two firms turned it down but Coast IRB took […]

Read More

Trilateral Cooperation Charter—Can We Count on Assurances of No Harmonization?

The Trilateral Cooperation Charter, or TCC, is an agreement signed in 2004 by Mexico, Canada, and the US. Its purpose is to increase communication, collaboration, and the exchange of information among the three countries in the areas of drugs, biologics, medical devices, food safety and nutrition—in theory, an exchange of “best practices.”

Read More